A cross sectional study to assess the severity of meibomian gland dysfunction and its association with dyslipidemia
DOI:
https://doi.org/10.18203/2349-3933.ijam20232917Keywords:
Dry eye, Dyslipidemia, Meibomian glands, Meibomian gland dysfunction, Meibomian gland lossAbstract
Background: Studies have linked increased cholesterol esters in meibomian secretions to patients with meibomian gland dysfunction. Dyslipidemia has been linked to the development of MGD. This study of serum lipid profile in established cases of MGD.
Methods: A cross sectional study was conducted in department of ophthalmology at Rajarajeswari medical college and hospital Kambipura, Bengaluru from January 2021 to June 2022. 75 study participants with clinical diagnosis of MGD were included.
Results: The mean age of the study participants was found to be 55.97±14.019. Mild MGD grade was found in 32% and 26.7% of the study participants in the right eye and left eye respectively. Moderate MGD grade was 38.7% and 42.7% of the study participants in the right and left eye respectively. 4% each of the study participants had very severe MGD grade in the right and left eye respectively. Marx line grading of 1 was found in 40% and 46.7% of the study participants in the right eye and left eye respectively. Marx line grading of 2 was found in 54.7% and 36% of the study participants in the right and left eye respectively. Marx line grading of 3 was 5.3% and 17.3% of the study participants in right left eye respectively. severity of MGD grading of the study participants increases, the Lipid profile values also increases. The association was statistically significant between the MGD grading and lipid profile.
Conclusions: MGD patients exhibit a higher degree of total cholesterol, LDL, lower degree of HDL in their serum lipid profiles than normal reference levels and the severity of MGD increases, the values of lipid profile increase. Elevated serum cholesterol was associated with MGD.
References
Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. Tfos dews ii definition and classification report. Ocular Surface. 2017;15(3):276-83.
Dua HS. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop. Ocular Surface. 2007;5(2):75-92.
Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci. 2011;52(4):1994.
Uchino M. The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye workshop. Ocular Surface. 2007;5(2):93-107.
Tomlinson A, Bron AJ, Korb DR, Amano S, Paugh JR, Pearce EI, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4): 2006.
Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS dews II epidemiology report. Ocular Surface. 2017;15(3):334-65.
McCarty C. The epidemiology of dry eye in Melbourne, Australia, Historical image. Ophthalmology. 1998;105(6):1114-9.
Jie Y, Xu L, Wu YY, Jonas JB. Prevalence of dry eye among adult Chinese in the Beijing Eye Study. Eye. 2009;23(3):688-93.
Hykin PG, Bron AJ. Age-related morphological changes in lid margin and meibomian gland anatomy. Cornea. 1992;11(4):334-42.
Yamaguchi M, Kutsuna M, Uno T, Zheng X, Kodama T, Ohashi Y. Marx line: fluorescein staining line on the inner lid as indicator of meibomian gland function. AM J Ophthalmol. 2006;141(4):669.
Shine WE, McCulley JP. The role of cholesterol in chronic blepharitis. Invest Ophthalmol Vis Sci. 1991; 32(8):2272-80.
Shine WE, McCulley JP. Polar lipids in human meibomian gland secretions. Curr Eye Res. 2003; 26(2):89-94.
Dao AH, Spindle JD, Harp BA, Jacob A, Chuang AZ, Yee RW. Association of dyslipidemia in moderate to severe meibomian gland dysfunction. Am J Ophthalmol. 2010;150(3):371375.
Pinna A, Blasetti F, Zinellu A, Carru C, Solinas G. Meibomian gland dysfunction and hypercholesterol-emia. Ophthalmology. 2013;120(12): 2385-9.
